|
XANTUS EMEA-LA. Xarelto® on prevention of stroke and non-central nervous system systemic embolism in patients with non-valvular atrial fibrillation in Eastern EU, Middle East, Africa (EMEA) and Latin America (LATAM): A non-interventional study
|
Ongoing
|
Xarelto
|
4
|
16691
|
Prince Sultan Cardiac Center (Qassim), Abdul Rahman Al-Mishari Hospital (Riyadh), King Fahad Medical City (Riyadh), King Faisal Specialist Hospital and Research Center (Riyadh), King Faisal Specialist Hospital and Research Center (Jeddah), King Khalid University Hospital (Riyadh), Dallah Hospital (Riyadh), Prince Sultan Cardiac Center (Riyadh)
|
|
Non-Interventional Cohort Study on the Utilization and Impact of Dual and Triple Therapies Based on Pegylated Interferon for the Treatment of Chronic Hepatitis C
|
Ongoing
|
Pegasys
|
4
|
MV25599
|
King Abdullah Medical City (Makkah), King Faisal Specialist Hospital and Research Center (Riyadh), Prince Sultan Military Medical City (Riyadh)
|
|
Impact on glycaemic control of the intensification of insulin therapy proposed by ADA/EASD guidelines with insulin glargine as pasal insulin plus a single daily dose of insulin glulisine at main meal : Basal plus strategy in real life
|
Ongoing
|
Lantus®/Apidra®
|
4
|
APIDR_L_05185
|
King Abdulaziz University Hospital (Jeddah), Armed Forces Hospital (Taif)
|
|
A 24 month, multicenter, randomized, open-label safety and efficacy study of concentration-controlled everolimus with reduced calcineurin inhibitor in de novo renal transplantation - Advancing renal TRANSplant eFficacy and safety Outcomes with an eveRolimus-based regiMen (TRANSFORM)
|
Ongoing
|
Everolimus
|
4
|
CRAD001A2433
|
Prince Sultan Military Medical City (Riyadh), King Fahad Specialist Hospital (Dammam)
|
|
A Prospective Multicentre Randomised Controlled Trial of Early Goal Directed Sedation Compared with Standard Care in Mechanically Ventilated Patients in Intensive Care
|
Ongoing
|
Dexmedetomidine
|
4
|
RC 12-079
|
King Abdulaziz Medical City NG (Riyadh), King Abdulaziz Medical City NG (Jeddah)
|
|
Global Registry Program on Long-Term Oral Anti-thrombotic TReatment In PAtients with Atrial Fibrillation.
|
Ongoing
|
Dabigatran (dabigatran etexilate = prodrug)
|
4
|
1160.129
|
King Fahad Medical City (Riyadh), King Faisal Hospital (Taif) , King Salman Bin AbdulAziz Hospital (Riyadh), King Fahad Hospital (Hofuf), Armed Forces Hospital (Southern Region) , Armed Forces Hospital (North West Region)
|
|
Prevalence and Patient Experience with Condylomas Study in Saudi Arabia
|
Ongoing
|
N/A
|
4
|
PREPEC
|
King Abdulaziz University Hospital (Jeddah), Prince Sultan Military Medical City (Riyadh) , King Fahad Medical City (Riyadh)
|
|
A Multinational Observational Study Assessing Insulin Use: Understanding the Challenges Associated With Progression of Therapy - The MOSAIc Type 2 Diabetes Study
|
Ongoing
|
N/A
|
4
|
F3Z-MC-B010
|
Al-Noor Specialist Hospital (Makkah), Armed Forces Hospital (Taif) , King Fahad Medical City (Riyadh)
|
|
Inhibitor Development in Previously Untreated Patients (PUPs) or Minimally Blood Component-Treated Patients (MBCTPs) When Exposed to Plasma-derived Von Willebrand Factor-Containing Factor VIII (VWF/FVIII) Concentrates and to Recombinant Factor VIII (rFVIII) Concentrates: An Independent, International, Multicentre, Prospective, Controlled, Randomised, Open Label, Clinical Trial)
|
Ongoing
|
PLASMA DERIVED Factor VIII Recombinant FVIII
|
4
|
ABB- 09 -001
|
King Faisal Specialist Hospital and Research Center (Riyadh)
|
|
Registry on Monitoring the Effectiveness and Tolerability of Basal (Plus/Bolus) Regimen with LantusÒ (Insulin Glargine) and ApidraÒ (Insulin Glulisine) in T2 Diabetes Mellitus Patients in Everyday Practice in Saudi
|
Ongoing
|
Lantus®
|
4
|
LANTUL06939
|
King Fahd Military Medical Complex (Dhahran), Armed Forces Hospital (Southern Region), Polyclinics in western province
|
